Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 10/20 | 0.52 |
| ▸ | FNTB | P49356 | 10/20 | 0.52 |
| ▸ | NOD2 | Q9HC29 | 3/20 | 0.48 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.48 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | F10 | P00742 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27156298 | 0.92 | FNTA (0.53) | FNTAFNTBNOD2NOD1KDM4E | |
| SCHEMBL27156308 | 0.90 | NOD2 (0.48) | FNTAFNTBNOD2NOD1ELANE | |
| SCHEMBL27156302 | 0.89 | FNTA (0.44) | FNTAFNTBNOD2NOD1KDM4E | |
| SCHEMBL27156312 | 0.87 | ELANE (0.46) | FNTAFNTBNOD2NOD1ELANE | |
| SCHEMBL27165736 | 0.80 | FNTA (0.54) | FNTAFNTBNOD2NOD1ELANE | |
| SCHEMBL27156313 | 0.79 | NOD2 (0.44) | NOD2NOD1KDM4ENPSR1RXFP1 | |
| SCHEMBL27210453 | 0.75 | FNTA (0.51) | FNTAFNTBKDM4EALDH1A1 | |
| SCHEMBL26931128 | 0.74 | FNTA (0.54) | FNTAFNTBNOD2NOD1ELANE | |
| SCHEMBL26930792 | 0.73 | FNTA (0.53) | FNTAFNTBNOD2NOD1KDM4E | |
| SCHEMBL30816139 | 0.73 | KMT2A (0.39) | FNTAFNTBKDM4ENPSR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11919900-B1 | 1-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents | King Faisal University (SA) | 2024-03-05 | — | — | US | claimed |
| US-11919900-B1 | 1-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents | King Faisal University (SA) | 2024-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11919900-B1 | 1-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents | BRD4, BET1, TALDO1 | FNTA 720/4885FNTB 79/4885NOD2 2638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.